Open AccessPeroxisome proliferator-activated receptor γ agonist reduces the severity of post-ERCP pancreatitis in rats
Author(s) -
Emma FolchPuy
Publication year - 2006
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v12.i40.6458
Subject(s) - rosiglitazone , pancreatitis , agonist , medicine , myeloperoxidase , endocrinology , pancreas , acute pancreatitis , peroxisome proliferator activated receptor , endoscopic retrograde cholangiopancreatography , edema , inflammation , receptor
To determine the effects of prophylactic peroxi-some proliferator-activated receptor (PPARgamma) agonist administration in an experimental model of post-endoscopic retrograde cholangiopancreatography (post-ERCP) acute pancreatitis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom